Advisory Research Inc Collegium Pharmaceutical, Inc Transaction History

Advisory Research Inc

  • $548 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018
SELL
$14.16 - $24.3 $711,851 - $1.22 Million
-50,272 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$21.79 - $28.29 $1.08 Million - $1.41 Million
-49,674 Reduced 49.7%
50,272 $1.2 Million
Q1 2018

May 15, 2018
BUY
$18.15 - $29.21 $1.81 Million - $2.92 Million
99,946 New
99,946 $2.55 Million

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.4M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email